276 related articles for article (PubMed ID: 17394936)
41. Synthetic surfactants with SP-B and SP-C analogues to enable worldwide treatment of neonatal respiratory distress syndrome and other lung diseases.
Johansson J; Curstedt T
J Intern Med; 2019 Feb; 285(2):165-186. PubMed ID: 30357986
[TBL] [Abstract][Full Text] [Related]
42. Advances with surfactant.
Turell DC
Emerg Med Clin North Am; 2008 Nov; 26(4):921-8, viii. PubMed ID: 19059091
[TBL] [Abstract][Full Text] [Related]
43. Lucinactant for the treatment of respiratory distress syndrome in neonates.
Piehl E; Fernandez-Bustamante A
Drugs Today (Barc); 2012 Sep; 48(9):587-93. PubMed ID: 23032799
[TBL] [Abstract][Full Text] [Related]
44. A pilot randomized, controlled trial of later treatment with a peptide-containing, synthetic surfactant for the prevention of bronchopulmonary dysplasia.
Laughon M; Bose C; Moya F; Aschner J; Donn SM; Morabito C; Cummings JJ; Segal R; Guardia C; Liu G;
Pediatrics; 2009 Jan; 123(1):89-96. PubMed ID: 19117865
[TBL] [Abstract][Full Text] [Related]
45. Designer surfactants. The next generation in surfactant replacement.
Holm BA; Waring AJ
Clin Perinatol; 1993 Dec; 20(4):813-29. PubMed ID: 8131368
[TBL] [Abstract][Full Text] [Related]
46. A randomized controlled trial of synchronized nasal intermittent positive pressure ventilation in RDS.
Bhandari V; Gavino RG; Nedrelow JH; Pallela P; Salvador A; Ehrenkranz RA; Brodsky NL
J Perinatol; 2007 Nov; 27(11):697-703. PubMed ID: 17703184
[TBL] [Abstract][Full Text] [Related]
47. Comparison efficacy of Curosurf and Survanta in preterm infants with respiratory distress syndrome.
Mirzarahimi M; Barak M
Pak J Pharm Sci; 2018 Mar; 31(2):469-472. PubMed ID: 29618436
[TBL] [Abstract][Full Text] [Related]
48. Analysis of dynamic surface properties of therapeutic surfactants and lung phospholipids.
Banerjee R; Puniyani RR; Bellare JR
J Biomater Appl; 2000 Oct; 15(2):140-59. PubMed ID: 11081642
[TBL] [Abstract][Full Text] [Related]
49. [Substitutive therapy with surfactants in premature infants with respiratory distress syndrome].
Liberatore A; Carrera G; Calciolari G; Coccia C; Coppalini B; Fulconis F; Moro G; Scimone F; Villa G; Minoli I
Ann Osp Maria Vittoria Torino; 1987-1988; 30():28-35. PubMed ID: 3334194
[TBL] [Abstract][Full Text] [Related]
50. Lung surfactant in an era of replacement therapy.
Notter RH; Shapiro DL
Pediatrics; 1981 Dec; 68(6):781-9. PubMed ID: 6275335
[TBL] [Abstract][Full Text] [Related]
51. Cost effectiveness of prevention and treatment of neonatal respiratory distress (RDS) with exogenous surfactant: what has changed in the last three decades?
Mugford M
Early Hum Dev; 2006 Feb; 82(2):105-15. PubMed ID: 16457971
[TBL] [Abstract][Full Text] [Related]
52. Surfactant replacement therapy for pulmonary diseases.
Pramanik AK; Holtzman RB; Merritt TA
Pediatr Clin North Am; 1993 Oct; 40(5):913-36. PubMed ID: 8414715
[TBL] [Abstract][Full Text] [Related]
53. On "A randomized, multicenter masked comparison trial of poractant alfa (Curosurf) versus beractant (Survanta) in the treatment of respiratory distress syndrome in preterm infants" (Am J Perinatol 2004;21:109-120).
Bancalari E
Am J Perinatol; 2004 Jul; 21(5):307-9. PubMed ID: 15232767
[No Abstract] [Full Text] [Related]
54. New generation synthetic surfactants.
Curstedt T; Calkovska A; Johansson J
Neonatology; 2013; 103(4):327-30. PubMed ID: 23736010
[TBL] [Abstract][Full Text] [Related]
55. Disulphide Bridges in Surfactant Protein B Analogues Affect Their Activity in Synthetic Surfactant Preparations.
Basabe-Burgos O; Johansson J; Curstedt T
Neonatology; 2019; 115(2):134-141. PubMed ID: 30453306
[TBL] [Abstract][Full Text] [Related]
56. The 5 W's of surfactant for respiratory distress syndrome of the premature infant.
Parmigiani S
J Matern Fetal Neonatal Med; 2004 Nov; 16 Suppl 2():25-7. PubMed ID: 15590430
[TBL] [Abstract][Full Text] [Related]
57. Animal-derived surfactants: where are we? The evidence from randomized, controlled clinical trials.
Ramanathan R
J Perinatol; 2009 May; 29 Suppl 2():S38-43. PubMed ID: 19399008
[TBL] [Abstract][Full Text] [Related]
58. Synthetic surfactant protein analogues.
Johansson J; Gustafsson M; Palmblad M; Zaltash S; Robertson B; Curstedt T
Biol Neonate; 1998 Sep; 74 Suppl 1():9-14. PubMed ID: 9730586
[TBL] [Abstract][Full Text] [Related]
59. Synthetic surfactant based on analogues of SP-B and SP-C is superior to single-peptide surfactants in ventilated premature rabbits.
Almlén A; Walther FJ; Waring AJ; Robertson B; Johansson J; Curstedt T
Neonatology; 2010 Jun; 98(1):91-9. PubMed ID: 20110733
[TBL] [Abstract][Full Text] [Related]
60. Pulmonary surfactant kinetics of the newborn infant: novel insights from studies with stable isotopes.
Carnielli VP; Zimmermann LJ; Hamvas A; Cogo PE
J Perinatol; 2009 May; 29 Suppl 2():S29-37. PubMed ID: 19399007
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
